Private specialist care in Leeds and HarrogateEnquiries welcome from across the UK

Research & developments

Oral treatments for endometriosis symptoms

More treatment options can make a difference. The important decision is which option fits your medical history and priorities.

Sources checked · Source published: 16 April and 4 June 2025

Read the evidence summary

What has been recommended?

NICE recommended relugolix–estradiol–norethisterone in April 2025 and linzagolix with hormonal add-back therapy in June 2025 for adults of reproductive age who have already had medical or surgical treatment for endometriosis.

These are oral GnRH antagonist options. Add-back therapy uses hormones to reduce some of the effects of lowering natural hormone levels.

Who might benefit?

Suitability depends on the symptoms being treated, earlier treatment, other health conditions, side effects and pregnancy plans. A new recommendation does not mean that someone doing well on an existing treatment needs to switch.

Your clinician can explain the expected benefit, risks, monitoring and what would lead to a treatment change. Prescribing and access arrangements should be confirmed with the relevant service.

Questions for your consultation

  • What is the goal of another hormonal treatment in my case?
  • How does it compare with my current treatment?
  • What are the implications for bone health and pregnancy planning?
  • What monitoring and review would I need?
  • What happens if it is ineffective or poorly tolerated?

Medicines, pain care and surgery have different roles. A recommendation should fit the whole treatment plan.

Information sources

General information to support your consultation. Individual assessment is needed to decide on treatment.

About our information and evidence summaries

The next conversation

Make space for
your questions.

Speak to the secretary for your chosen consultant about a first appointment or a second opinion.

Get in touch

Website information

About this website

This site provides general information about the private service. It does not provide individual diagnosis or treatment advice.

There is no patient information form or clinical document upload on this website. Email and phone links open your own email or phone application. Please ask the relevant secretary how to share clinical information securely.

The website itself adds no analytics or advertising cookies. Hosting and access services may process technical information to deliver the site.